CC
OACC

Centiva Capital’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Centiva Capital’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,400
Closed -$429K – 2104
2025
Q4 		$429K Hold
40,400
– – ﹤0.01% 757
2025
Q3 		$423K Hold
40,400
– – ﹤0.01% 689
2025
Q2 		$423K Hold
40,400
– – 0.01% 1035
2025
Q1 		$412K Buy
+40,400
New +$405K 0.01% 916

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Centiva Capital's OACC Position: Q1 2026 in Review

Centiva Capital sold out of Oaktree Acquisition Corp III Life Sciences (OACC) in Q1 2026, closing a stake of 40,400 shares — an estimated $429K sold.

Centiva Capital first reported a position in OACC in Q1 2025 and held it in 4 quarters. The position peaked at $429K in Q4 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Centiva Capital reported no remaining Oaktree Acquisition Corp III Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 40,400 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $429K.
  • Centiva Capital first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and held it in 4 quarters.
  • Centiva Capital's Oaktree Acquisition Corp III Life Sciences position peaked at $429K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.